Chronic Hydralazine Use Linked to Multiorgan Failure
A recent case report highlights how long-term use of this blood pressure medication can trigger a rare autoimmune response.
Updated on Oct. 1, 2026 in Heart Disease
A 71-year-old patient developed life-threatening multiorgan failure after four months of taking hydralazine for hypertension. The patient, whose case was detailed in an August 2026 report, suffered from symptoms including abdominal distress and a severe inflammatory condition.
Why it matters
This case illustrates the importance of monitoring for rare but severe adverse reactions to common blood pressure treatments. When unexplained systemic symptoms arise, clinicians must evaluate whether ongoing medication use could be the underlying cause.
A clinical study documented a 71-year-old man who developed an autoimmune syndrome after taking 75 mg of hydralazine three times daily for four months. Testing confirmed the presence of ANCA, antinuclear, and antihistone antibodies following the onset of multiorgan failure.
The players
JACC: Case Reports
A peer-reviewed medical journal published by the American College of Cardiology that focuses on cardiovascular clinical cases.
The details
The patient experienced an autoimmune reaction classified as hydralazine-induced autoimmune syndrome, which combined elements of ANCA-associated vasculitis and drug-induced lupus erythematosus. This systemic response led to a large pericardial effusion, requiring the drainage of 650 mL of fluid. The inflammatory cascade eventually caused severe respiratory failure and acute kidney injury.
Timeline
Four months prior to the hospital stay, the patient started hydralazine at 75 mg three times daily.
Abdominal pain, diarrhea, and vomiting persisted for three weeks before admission.
On day 17 of the hospital stay, the patient experienced respiratory failure, bradycardia, and acute kidney injury.
The case study was officially published on August 18, 2026.
Health Landscape
This case highlights the ongoing challenges in identifying rare drug-induced autoimmune reactions among patients managing multiple chronic conditions. It underscores the critical need for vigilance in monitoring patients on long-term hypertension therapies for unexpected systemic decline.
If you take hydralazine for blood pressure, be aware of new, unexplained systemic symptoms like severe abdominal pain or persistent fatigue. It is worth discussing with your doctor any concerns about your medication regimen and whether you require monitoring for side effects.
The takeaway
Chronic medication use can occasionally trigger unexpected autoimmune responses that mimic other serious health crises. Patients should remain vigilant and track any new or unusual symptoms while undergoing long-term cardiovascular treatment.
Further reading
For more on managing heart conditions and associated therapies, visit our Heart Disease section.
More information
Read the full details of the JACC: Case Reports clinical study on cardiovascular safety.
Source note: This article includes information reported by Renal and Urology News.
